Crowdfunding to Combat the Coronavirus Act
Latest action · Mar 12, 2020 Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 12, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Crowdfunding to Combat the Coronavirus Act
This bill (1) establishes an award for the successful development of a vaccine for the coronavirus (i.e., the virus that causes COVID-19), and (2) extends specified Securities and Exchange Commission (SEC) registration exemptions to issuers of securities responding to the COVID-19 outbreak.
The bill provides appropriations for the purpose of awarding a prize to the creator of a vaccine that (1) reduces the incidence and mortality rate of COVID-19 by more than 50%, and (2) is affordable and widely available to the public.
Additionally, an issuer of securities that is developing a coronavirus vaccine, researching or producing medical equipment related to COVID-19, or researching or producing technology related to preventing the spread of COVID-19 may qualify for an exemption from SEC registration requirements regardless of the size of the issuer's offers or sales. Furthermore, these issuers are not subject to joint and several liability for certain claims.
The provisions set forth in this bill expire the earlier of (1) the date the prize is awarded, or (2) three years after enactment.
The Government Accountability Office must report on the bill's effects.
Cosponsors 4
Members who signed on, in the order they did. All signed on Mar 12, 2020.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KY | Andy Barr | Original | Mar 12, 2020 |
| R-MO | Ann Wagner | Original | Mar 12, 2020 |
| R-MI | Bill Huizenga | Original | Mar 12, 2020 |
| R-OH | Steve Stivers | Original | Mar 12, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Financial Services Committee | Referred Mar 12, 2020 |
| House | Energy and Commerce Committee | Referred Mar 12, 2020 |
Actions 2
Everything that happened, newest first.
- Mar 12, 2020Introduced in House
- Mar 12, 2020Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 48, March 12, 2020, page H1671.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To expand certain securities exemptions to respond to COVID-19, to establish an X-prize for creating an effective COVID-19 vaccine, and for other purposes.
- Short Title(s) as Introduced
- Crowdfunding to Combat the Coronavirus Act
Subjects
Assigned by the Library of Congress. Policy area: Finance and Financial Sector.
- Cardiovascular and respiratory health
- Congressional oversight
- Educational technology and distance education
- Emergency medical services and trauma care
- Finance and Financial Sector
- Financial services and investments
- Government studies and investigations
- Health promotion and preventive care
- Health technology, devices, supplies
- Immunology and vaccination
- Infectious and parasitic diseases
- Internet and video services
- Internet, web applications, social media
- Research and development
- Securities
Text 1
Each version as it was printed, newest first.
- Mar 12, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.